VeriTeQ Enhances its Patent Portfolio by Filing Two New Patents to Protect its Position as a Leader in Breast Implant Identification and Safety TechnologiesSeptember 18, 2013 8:30 am | by Business Wire | News | Comments
Digital Angel Corporation, a provider of implantable medical device identification and radiation dose measurement technologies, following its recent share exchange with VeriTeQ Acquisition Corporation (“VeriTeQ”), announced today that VeriTeQ has enhanced its patent portfolio by filing two new patents with the U.S. Patent and Trademark Office...
A voice-analysis program run on a tablet could help high school and youth coaches recognize concussions on the sidelines of football and other high-impact sport games. After identifying concussions in collegiate boxers in a preliminary study, University of Notre Dame researchers will soon test the app on approximately 1,000 youth and high school football players.
While Metrigraphics LLC certainly does not speak for the medical device OEM industry, as a custom contract manufacturer of leading edge micro components, we certainly feel the impacts of various external elements on the ebb and flow of R&D and innovation activities of the OEMs.
EAO Corporation has developed a unique, intelligent, configurable sound module to alert people for potentially dangerous situations, such as in automatic train doors, pedestrian crossings, and mechanical doors lifts.
Netzer Precision Motion Sensors has taken a revolutionary position sensing technology, originally developed for harsh environment specialized applications, and made it available for today’s broader range of defense, homeland security, aerospace and instrumentation motion control requirements.
Bring additional power from the wall direct to your work station. The PTRC3 from Mockett has an ultra-thin profile, lying nearly flat on the surface, eliminating any tripping hazards. It is also safe for casters, carts and wheelchairs to smoothly pass over.
Haydon Kerk Motion Solutions has introduced the latest addition to the IDEA Drive line of sophisticated stepper motor controllers.
Life sciences is one industry that is currently undergoing a turbulent development environment. Major advancements such as next-generation DNA sequencing and molecular imaging are expected to drive growth in categories such as immunochemistry and genetic testing. Add to this that changes in government regulations and market conditions are forcing life science OEMs to build their products using faster, smaller more modular technologies.
Medical device titans Medtronic and Boston Scientific cut the ribbon on new facilities overseas this week, looking to develop new technologies that cater to markets in Ireland and China. Minnesota-based Medtronic announced a new $10-million-dollar "brainstorming" center at its Galway, Ireland campus...
With funding from the National Institute for Health Research, experts at The University of Nottingham have developed a highly accurate prototype technique which can produce a detailed ‘spectroscopic fingerprint’ of each tissue layer removed during surgery.
Routine screening has been touted as the most effective way to stem cancer deaths, but it may instead put patients in harm's way, according to American Cancer Society chief medical officer Dr. Otis Brawley. Speaking at a seminar last week, Brawley warned that hospitals recommending regular screening may be looking out for their profits rather than their patients.
Smith & Nephew, the global medical technology business, announces the US introduction of DURAFIBER Ag antimicrobial gelling fiber dressing. This new offering in the DURAFIBER portfolio combines the highly absorbent, gelling fiber filler dressing with the benefits of silver (Ag).
According to a new report from industry analyst firm NanoMarkets, the global medical polymer market will grow from $2.3 billion (USD) in 2013 to over $3.5 billion in 2018. The report titled, “Worldwide Medical Polymer Markets 2013-2020” identifies the current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising.
Logical Images, the Rochester-based company that created the nation's only widely used diagnostic decision tool, VisualDx, announced today that it has been awarded a U.S. patent for its unique visual diagnostic process and system that, in addition to other features, selectively presents and displays images based upon descriptive characteristics of a patient.
Surgery is the cornerstone of oncology treatment, and molecularly-targeted fluorescent imaging agents have the potential to guide surgical resection by highlighting the biological margins of the disease. However, development and testing of such molecular imaging agents has been lacking.